Sernova Aktie - SVA

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Current Price

1,57

Gebot

1,55

Fragen

1,61

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Marktkapitalisierung

510,76M

Handelsende

1,57

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

Ausgegebene Aktien

325.325.000

Dividendenrendite

Kurs-Gewinn-Verhältnis

-1,62

Gewinn pro Aktie (EPS)

-0,1

Erlöse

Nettogewinn

-32,19M

Sektor

Pharmaceutical Preparations

Branche

Pharmaceutical Preparations

Website

www.sernova.com

Hauptsitz

Vancouver, British Columbia, Can

Gegründet

Sernova Corp is listed in the Pharmaceutical Preparations sector of the TSX Venture Börse with ticker SVA. The last closing price for Sernova was $1,57. Over the last year, Sernova shares have traded in a share price range of $ 0,00 to $ 0,00.

Sernova currently has 325.325.000 shares in issue. The market capitalisation of Sernova is $510,76 million. Sernova has a price to earnings ratio (PE ratio) of -1.62.

Life Sciences Companies Investors Presentations Now Available for On-Demand Viewing

NEW YORK, March 29, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the...

Sernova to Webcast Live at Life Sciences Investor Forum March 25th

LONDON, Ontario, March 22, 2021 (GLOBE NEWSWIRE) -- Sernova Corp. (OTCQB:SEOVF)(TSX-V:SVA)(FSE/XETRA:PSH), a...

Virtual Conference for Life Sciences Companies Broadcast Live March 25th, 2021

NEW YORK , March 19, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its...

PURA SVA - Health Stocks Exhibit Healthy News, Robust Share Hikes

BAYSTREET -- June 18, 2020 -- InvestorsHub NewsWire -- via Glenn Wilkins -- It’s probably the farthest from the minds...

Sernova Confirms Enduring Levels of Fasting C-Peptide in Bloodstream of First Patient in Phase I/II Clinical Trial for Type-A

Sernova Confirms Enduring Levels of Fasting C-Peptide in Bloodstream of First Patient in its Phase I/II Clinical Trial for Type-1...

Sernova Announces First Transplantation of Therapeutic Cells in Cell Pouch for the Company's Phase I/II U.S. Clinical Study

Sernova Announces First Transplantation of Therapeutic Cells in Cell Pouch for the Company's Phase I/II U.S. Clinical Study for Diabetes LONDON...

Sernova Completes Oversubscribed Private Placement of $2,754,000

LONDON, Ontario, July 23, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH...

Sernova Initiates Patient Screening and Recruitment for its US Clinical Trial for Diabetes

Sernova Initiates Patient Screening and Recruitment for its US Clinical Trial for DiabetesLondon, ON -- July 5, 2018 -- InvestorsHub NewsWire...

Sernova Initiates Patient Screening and Recruitment for its US Clinical Trial for Diabetes

LONDON, Ontario, July 05, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (“Sernova” or the “Company”) (TSX-V:SVA...

Sernova Announces University of Chicago Institutional Review Board (IRB) Approval of the FDA-cleared Therapeutic Cell Pouch C...

LONDON, Ontario, May 14, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

SVA - Frequently Asked Questions (FAQ)

What is the current Sernova share price?

The current share price of Sernova is $ 1,57

How many Sernova shares are in issue?

Sernova has 325.325.000 shares in issue

What is the market cap of Sernova?

The market capitalisation of Sernova is CAD 510,76M

What is the 1 year trading range for Sernova share price?

Sernova has traded in the range of $ 0,00 to $ 0,00 during the past year

What is the PE ratio of Sernova?

The price to earnings ratio of Sernova is -1,62

What is the reporting currency for Sernova?

Sernova reports financial results in CAD

What is the latest annual profit for Sernova?

The latest annual profit of Sernova is CAD -32,19M

What is the registered address of Sernova?

The registered address for Sernova is SUITE 1500 - 1055 WEST GEORGIA STREET, VANCOUVER, BRITISH COLUMBIA, V6E 2N7

What is the Sernova website address?

The website address for Sernova is www.sernova.com

Which industry sector does Sernova operate in?

Sernova operates in the PHARMACEUTICAL PREPARATIONS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
BOCABocana Resources Corp	$ 0,01 (100,00%)	1.000
ROVRRover Critical Minerals Corp	$ 0,02 (100,00%)	236,56k
PONDPond Technologies Holdings Inc	$ 0,01 (100,00%)	88,87k
ADEAdex Mining Inc	$ 0,01 (100,00%)	34k
GNFIGenifi Inc	$ 0,01 (100,00%)	840k
VMY.HVoice Mobility International Inc	$ 0,01 (-60,00%)	1.000
MTKMontauk Metals Inc	$ 0,005 (-50,00%)	21k
SOP.HSoperior Fertilizer Corp	$ 0,005 (-50,00%)	181,46k
CCDCascadero Copper Corporation	$ 0,005 (-50,00%)	64k
SPZSuperBuzz Inc	$ 0,11 (-37,14%)	69,5k
AAZAzincourt Energy Corp	$ 0,04 (33,33%)	4,6M
AFMAlphamin Resources Corp	$ 0,51 (13,33%)	3,96M
GSHRGoldshore Resources Inc	$ 0,345 (15,00%)	2,53M
MURMurchison Minerals Ltd	$ 0,02 (33,33%)	1,75M
QNCQuantum Emotion Corp	$ 0,69 (-1,43%)	1,6M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Sernova Corp (SVA)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Über Sernova Corp

SVA Neueste Nachrichten

Life Sciences Companies Investors Presentations Now Available for On-Demand Viewing

Sernova to Webcast Live at Life Sciences Investor Forum March 25th

Virtual Conference for Life Sciences Companies Broadcast Live March 25th, 2021

PURA SVA - Health Stocks Exhibit Healthy News, Robust Share Hikes

Sernova Confirms Enduring Levels of Fasting C-Peptide in Bloodstream of First Patient in Phase I/II Clinical Trial for Type-A

Sernova Announces First Transplantation of Therapeutic Cells in Cell Pouch for the Company's Phase I/II U.S. Clinical Study

Sernova Completes Oversubscribed Private Placement of $2,754,000

Sernova Initiates Patient Screening and Recruitment for its US Clinical Trial for Diabetes

Sernova Initiates Patient Screening and Recruitment for its US Clinical Trial for Diabetes

Sernova Announces University of Chicago Institutional Review Board (IRB) Approval of the FDA-cleared Therapeutic Cell Pouch C...

SVA - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Sernova Corp (SVA) Börsenkurse

Sernova Corp (SVA)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Über Sernova Corp

SVA Neueste Nachrichten

Life Sciences Companies Investors Presentations Now Available for On-Demand Viewing

Sernova to Webcast Live at Life Sciences Investor Forum March 25th

Virtual Conference for Life Sciences Companies Broadcast Live March 25th, 2021

PURA SVA - Health Stocks Exhibit Healthy News, Robust Share Hikes

Sernova Confirms Enduring Levels of Fasting C-Peptide in Bloodstream of First Patient in Phase I/II Clinical Trial for Type-A

Sernova Announces First Transplantation of Therapeutic Cells in Cell Pouch for the Company's Phase I/II U.S. Clinical Study

Sernova Completes Oversubscribed Private Placement of $2,754,000

Sernova Initiates Patient Screening and Recruitment for its US Clinical Trial for Diabetes

Sernova Initiates Patient Screening and Recruitment for its US Clinical Trial for Diabetes

Sernova Announces University of Chicago Institutional Review Board (IRB) Approval of the FDA-cleared Therapeutic Cell Pouch C...

SVA - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS